Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02142985Phase 2Completed
Phase 2, open-label, single-arm trial, sponsored by Université de Monastir. Primary endpoint: central venous oxygen saturation (ScvO2) variation at 10 minutes. Started Apr 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02142985.